Assistive Product SUPROknee 20 Grad

Product Type:

Orthosis for immobilizing the knee joint in a flexed position

Indications:

  • Conservative therapy for collateral ligament lesions
  • Cruciate ligament instabilities
  • Meniscus damage
  • Traumatic or degenerative knee joint changes
  • Patellar dislocation
  • Post-traumatic/post-operative immobilization

Contraindications:

  • Thrombosis of the deep veins of the lower leg and thigh

Description:

SUPROknee is used to immobilize the knee joint in 20 degrees of extension. The orthosis covers the upper and lower leg and is closed with straps. The integrated silicone nubs at calf level provide the orthosis with a reliable anti-slip effect. The auxiliary scales on the outside help to set the correct circumference on the upper and lower leg. The product can be worn on the right and left.

Features / Components:

  • Three-part design for optimum adaptation
  • Anti-slip silicone nubs in the calf area
  • Pre-setting for upper and lower leg circumference
  • Auxiliary scales for easier adaptation to the upper and lower leg
  • Available in three different lengths (can be used on the left and right)

Price (without guarantee):

The price is available on request from the manufacturer / distributor.

SHI-Number:

SHI-Medical Technical Aids Register | 23.04.01.1039

Product Information from the Manufacturer / Distributor:

Further Product Details

REHADAT does not sell any products

Please contact the manufacturer or distributor.

Manufacturer:

Oped GmbH
Medizinpark 1
83626 Valley / Oberlaindern
Telephone: 08024 60818-210 Email: mail@oped.de Homepage: https://oped.de

Distributor:

Oped GmbH
Medizinpark 1
83626 Valley / Oberlaindern
Telephone: 08024 60818-210 Email: mail@oped.de Homepage: https://oped.de

Technical Data:

Lengths: Knee angle:
40 cm 20 degrees
50 cm 20 degrees
60 cm 20 degrees

Keywords

ISO

Search for similar prodcuts in REHADAT:

Search for similar products in EASTIN throughout Europe:

ICF Items

Reference Number:

IW/061209.001


Last Update: 29 Apr 2025